Related Experiment Video
Updated: Aug 9, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
FANCD2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma
1Department of Orthopaedic, Minhang Hospital, Fudan University, No.170, Xinsong Road, Xinzhuang Town, Minhang District, Shanghai City, 201199, China.
Background:
This research aimed to investigate the roles of fanconi anemia complementation group D2 (FANCD2) on the regulation of ferroptosis in osteosarcoma progression.
Methods:
The function of FANCD2 on cell viability, invasion, migration, and tumor growth were explored. FANCD2 and pathway-related genes were determined by western blot. Ferroptosis-associated markers were determined, including lipid peroxidation, labile iron pool (LIP), ferrous iron (Fe2+), and ferroptosis-related genes.
Results:
FANCD2 expression was increased in osteosarcoma cells. FANCD2 knockdown reduced cell viability, invasion, and migration of osteosarcoma cells. FANCD2 knockdown regulated ferroptosis-related gene expression, and distinctly increased the levels of LIP, Fe2+, and lipid peroxidation, and these effects were reversed by a ferroptosis inhibitor Fer-1. In addition, JAK2 and STAT3 expression were reduced by silencing of FANCD2, and STAT3 activator (colivelin) distinctly reversed tumor suppressor effects of FANCD2 silencing on osteosarcoma development.
Conclusion:
These findings suggested that FANCD2 silencing could suppress osteosarcoma cell viability, migration, invasion, and tumor growth, and induced ferroptosis by regulating the JAK2/STAT3 axis. These findings may provide novel therapeutic ideas for clinical treatment of osteosarcoma.
Insights
Fanconi anemia complementation group D2 (FANCD2) promotes osteosarcoma progression. Silencing FANCD2 induces ferroptosis and inhibits tumor growth by regulating the JAK2/STAT3 pathway.
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Mechanisms
Background:
- Osteosarcoma progression is a complex process involving multiple molecular pathways.
- Fanconi anemia complementation group D2 (FANCD2) is implicated in DNA repair and genomic stability.
- The role of FANCD2 in regulating ferroptosis during osteosarcoma development requires further investigation.
Purpose of the Study:
- To elucidate the function of FANCD2 in regulating ferroptosis in osteosarcoma.
- To explore the impact of FANCD2 on osteosarcoma cell viability, invasion, migration, and tumor growth.
- To investigate the underlying molecular mechanisms, including the JAK2/STAT3 axis.
Main Methods:
- Western blot analysis to assess FANCD2 and pathway-related gene expression.
- Assessment of ferroptosis markers: lipid peroxidation, labile iron pool (LIP), and ferrous iron (Fe2+).
- Functional assays including cell viability, invasion, and migration assays; in vivo tumor growth studies.
Main Results:
- FANCD2 expression was elevated in osteosarcoma cells.
- FANCD2 knockdown significantly reduced cell viability, invasion, migration, and tumor growth.
- FANCD2 silencing increased ferroptosis markers (LIP, Fe2+, lipid peroxidation), effects reversed by Fer-1.
- FANCD2 knockdown decreased JAK2 and STAT3 expression; STAT3 activation reversed the tumor-suppressive effects.
Conclusions:
- FANCD2 silencing suppresses osteosarcoma progression by inducing ferroptosis.
- The JAK2/STAT3 signaling pathway is a key mediator of FANCD2's role in osteosarcoma.
- Targeting FANCD2 and the JAK2/STAT3 axis offers potential therapeutic strategies for osteosarcoma.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Inhibition of Cdk Activity
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

